clinical trial · NCT04008186
A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone
Biogen·phase1·completed·n = 61
Healthy Adult SubjectsOmaveloxoloneMidazolam oral solutionRepaglinide 1 MGMetFORMIN 500 Mg Oral TabletRosuvastatinDigoxin tabletGemfibrozil TabletsItraconazole capsule
brief summary
This study will assess the potential for clinical drug-drug interactions between omaveloxolone and a number of substrates and inhibitors of metabolic enzymes and drug transporters.
started
Jun 14, 2019
primary completion
Aug 18, 2019
completion
Aug 28, 2019
last updated
May 30, 2025
official title
A Phase 1, Open-Label, 4-Part, Drug-Drug Interaction Study With Omaveloxolone in Healthy Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol